UROVIST MEGLUMINE DIU/CT Drug Patent Profile
✉ Email this page to a colleague
When do Urovist Meglumine Diu/ct patents expire, and when can generic versions of Urovist Meglumine Diu/ct launch?
Urovist Meglumine Diu/ct is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in UROVIST MEGLUMINE DIU/CT is diatrizoate meglumine. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST MEGLUMINE DIU/CT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 890 |
Formulation / Manufacturing: | see details |
DailyMed Link: | UROVIST MEGLUMINE DIU/CT at DailyMed |
US Patents and Regulatory Information for UROVIST MEGLUMINE DIU/CT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | UROVIST MEGLUMINE DIU/CT | diatrizoate meglumine | INJECTABLE;INJECTION | 087739-001 | Sep 23, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |